QNTM Quantum BioPharma Ltd.
Company Analysis
Latest News
🟢 Quantum BioPharma Surges 11.46% After Strong Q2 Results and FDA Clearance for Lucid-MS Phase 2
Quantum BioPharma is trading at $3.60 (+11.46%) today, following the release of robust Q2 2026 financial results and the recent FDA clearance for Lucid-MS to...
🟢 Quantum BioPharma is trading 5% up today after Q2 results and stronger liquidity
Quantum BioPharma is trading 5.11% up now at $3.40 after reporting second-quarter 2026 results and stronger liquidity on August 14, 2026. - Reported...
🟢 Quantum BioPharma is trading 7.43% up in pre-market after a 7.18% prior-session decline
Quantum BioPharma is trading at $3.47 (+7.43%) in pre-market, rebounding after a 7.18% decline on August 13. - No fresh company-specific announcement was...
🔴 Quantum BioPharma is trading 10.34% down today with no fresh company-specific catalyst identified
Quantum BioPharma is trading 10.34% down at $3.12 with no fresh company-specific catalyst identified for August 13, 2026. - The latest major announcement was...
🔴 Quantum BioPharma is trading 6.49% down today — no fresh company-specific catalyst identified
Quantum BioPharma is trading 6.49% down at $3.25, despite broader U.S. markets moving higher on cooler inflation and easing interest-rate concerns; no fresh...
🔴 Quantum BioPharma is trading 7.18% down today in pre-market
Quantum BioPharma is trading at $3.23, down 7.18%, after no fresh company-specific catalyst was identified for August 13, 2026. • The recent FDA clearance for...
🔴 Quantum BioPharma is trading 5% down in after-hours trading with no fresh company-specific catalyst identified
Quantum BioPharma is trading 5.17% down now at $3.30 in after-hours trading, with no fresh August 12 company-specific announcement or earnings release...
🟢 Quantum BioPharma is trading 5% up today after FDA approval moved Lucid-MS into Phase 2
Quantum BioPharma is trading at $3.64 (+5.20%) after the FDA approved its Investigational New Drug application for Lucid-MS on August 10, 2026, allowing the...
🟢 Quantum BioPharma is trading 8.38% up in pre-market after FDA cleared Lucid-MS for Phase 2 development
Quantum BioPharma is trading 8.38% up at $3.75 after the FDA approved its Investigational New Drug application for Lucid-MS on August 10, 2026, allowing the...
🟢 Quantum BioPharma is trading 12.75% up today after FDA cleared Lucid-MS IND for Phase 2 trial
Quantum BioPharma is trading 12.75% up now at $3.89 after the FDA cleared its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial for...
Quantum BioPharma Clears a Key FDA Hurdle for Its MS Drug — But Can a Micro-Cap Turn One Green Light Into Real Value?
Shares of Quantum BioPharma Ltd. surged as much as 7.5% to $3.71 after the company announced the FDA cleared its investigational new drug (IND) application for...
🟢 Quantum BioPharma is trading 7.54% up today after FDA approval of Lucid-MS IND
Quantum BioPharma is trading at $3.71 (+7.54%) after the FDA approved Quantum BioPharma’s IND application for Lucid-MS. - The clearance enables the company to...
🔴 Quantum BioPharma is trading 6.08% down today with no verified company-specific catalyst identified
Quantum BioPharma is trading 6.08% down at $3.24 after closing at $3.45 on August 7, 2026, with no verified company-specific announcement, earnings release, or...
🔴 Quantum BioPharma is trading 5.8% down in pre-market with no verified catalyst
Quantum BioPharma is trading 5.8% down at $3.25, after closing at $3.45 on August 7, 2026; no verified company-specific catalyst has been identified for the...
🟢 Quantum BioPharma is trading 10.84% up today amid biotech sentiment
Quantum BioPharma is trading at $3.55 (+10.84%), with broader biotech sentiment supported by argenx’s $2.2 billion Forte Biosciences acquisition. • No...
🔴 Quantum BioPharma is trading 7.12% down in after-hours trading despite broader biotech M&A speculation
Quantum BioPharma is trading 7.12% down at $3.00, with no verified company-specific announcement or earnings release identified for August 6. - The regular...
🟢 Quantum BioPharma is trading 11.38% up today as biotech M&A speculation lifts sector
Quantum BioPharma is trading 11.38% up at $3.23, with biotech-sector strength providing the clearest explanation for the August 6, 2026 move. - The XBI...
🟢 Quantum BioPharma is trading 6.55% up today amid biotech M&A activity
Quantum BioPharma is trading at $3.09, up +6.55%, as biotech-sector strength supports the move. • XBI is up 2.09% during regular trading. • Sector sentiment...
🔴 Quantum BioPharma is trading 8.2% down today in a reversal of recent gains
Quantum BioPharma is trading at $2.80 (-8.20%) today, giving back a portion of the prior session’s 5.54% gain. • The decline appears to be driven by intraday...
Quantum BioPharma Ltd. Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
For the second quarter of 2026, analysts anticipate Quantum BioPharma will report a consensus revenue of $1.90 million and an earnings per share loss of $0.51,...